# Neogenomics Inc: Form 8-K, filed Oct 28, 2025

- Company: [Neogenomics Inc](/companies/neo.md) (CIK 1077183)
- Form: 8-K
- Filed: 2025-10-28
- Accepted by EDGAR: Oct 28, 2025, 11:09 ET
- Period: 2025-10-28
- Accession: 0001077183-25-000172
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000172/neo-20251028.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000172/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1077183/000107718325000172/neo-20251028.htm

Filed Oct 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001077183-25-000172. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.